ArticleKidney medicine2026
Outcome of Peritonitis in Automated Peritoneal Dialysis: A Cohort Study.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of a nomogram for peritoneal dialysis-associated peritonitis.Renal failure · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rational & Objectives: Peritonitis is a serious complication of peritoneal dialysis (PD). Current treatment guidelines are directed toward patients receiving continuous ambulatory PD (CAPD), whereas the optimal treatment for those receiving automated PD (APD) is less clear. In this study, we compared the bacteriology and treatment outcomes of peritonitis episodes between patients receiving APD and CAPD and, for peritonitis episodes in patients receiving APD, we studied the difference in clinical outcomes between intermittent and continuous dosing of intraperitoneal antibiotics. Study Design: Single-center, retrospective cohort study. Setting & Participants: One hundred and seventy-six APD peritonitis episodes from 2007 to 2021 were compared to 352 CAPD episodes, matched for age, sex, and diabetes status. Exposures: Mode of PD; intermittent versus continuous dosing of intraperitoneal antibiotics. Outcomes: Primary outcome was the rate of complete cure. Analytical Approach: Groups were compared by χ Results: The APD group had higher complete cure rates than the CAPD group (88% vs 81%, Limitations: Retrospective study; small subgroup size. Conclusions: Peritonitis episodes in patients receiving APD had better treatment outcomes than those receiving CAPD. In the APD group, treatment with intermittent dosing of intraperitoneal antibiotics had better primary response rate and complete cure rate than those treated with continuous regimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.